Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
-NSE 957.00 
4.25(0.44%) 12:03AM EDT
| Prev Close: | 961.25 |
|---|
| Open: | 951.00 |
|---|
| Bid: | 956.80 |
|---|
| Ask: | 957.00 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 943.00 - 959.50 |
|---|
| 52wk Range: | 580.00 - 1,084.80 |
|---|
| Volume: | 84,885 |
|---|
| Avg Vol (3m): | 1,012,130 |
|---|
| Market Cap: | 987.82B |
|---|
| P/E (ttm): | 33.00 |
|---|
| EPS (ttm): | 29.00 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in INR.
Headlines
- Teva and Sun Pharma fined $2.15bn for patent breachat Financial Times(Wed, Jun 12)
- Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suitReuters(Wed, Jun 12)
- Severn Trent deal blow hits 'merger arb' fundsat Reuters(Wed, Jun 12)
- Severn Trent deal blow hits "merger arb" fundsat Reuters(Wed, Jun 12)
- Teva, Sun Pharma to pay $2.15 bln to settle Pfizer patent suitat Reuters(Wed, Jun 12)
- Pfizer settles patent lawsuit with Teva, Sun Pharma for $2.15 blnat Reuters(Wed, Jun 12)
- Meda tumbles 8.1% after denying merger speculationat Financial Times(Wed, Jun 5)
- Sweden's Meda sale talks founder on valuation: sourceat Reuters(Wed, Jun 5)
- BRIEF-Drug firm Meda expands collaboration with the Indian pharma Ciplaat Reuters(Wed, Jun 5)
- Swedish drugmaker Meda says not in sale talksat Reuters(Wed, Jun 5)
- Swedish drug firm Meda says not in discussions over possible saleat Reuters(Wed, Jun 5)
- NORDIC STOCKS - Factors to watch on June 3at Reuters(Mon, Jun 3)
- India's Sun Pharma in talks to buy Sweden's Meda for $5-$6 bln-sourcesat Reuters(Fri, May 31)
- India's Sun Pharma in talks to buy Sweden's Meda for $5-$6 billion: sourcesReuters(Fri, May 31)
- Indian stocks to watch-May 29at Reuters(Tue, May 28)
Reports
- No Reports available for SUNPHARMA.NS at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 8.83 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Sun Pharmaceutical Industries Limited, a specialty pharma company, manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.
View More